Navigation Links
Palatin Technologies, Inc. to Present at the 24th Annual Piper Jaffray Healthcare Conference
Date:11/20/2012

CRANBURY, N.J., Nov. 20, 2012 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) announced that it will be presenting at the 24th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27, 2012 at 3:10 p.m. Eastern Time.  The conference will be held at The New York Plaza, New York.

Carl Spana, Ph.D., President and Chief Executive Officer of Palatin Technologies, will provide an update on Palatin's corporate and development programs.  A live audio broadcast will be available on the "Investors" section of Palatin's website at www.palatin.com. The live audio broadcast will be available through December 3, 2012.

About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin's website at http://www.palatin.com


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
3. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
4. Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
5. Palatin Technologies, Inc. To Report Fiscal Year 2012 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2012
6. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012
7. Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration
8. Palatin Technologies, Inc. Announces Pricing of $35 Million Private Placement of Common Stock and Warrants
9. Palatin Technologies, Inc. To Report Fiscal Year 2012 Fourth Quarter Results; Teleconference and Webcast to be held on September 11, 2012
10. Palatin Technologies Provides Update Regarding Its Obesity Research/Development Collaboration with AstraZeneca
11. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... interface is the device," Nobel laureate Herbert Kroemer ... be found at the junctures where layers of ... nanotechnology, the interfaces between layers of metal oxides ... high-tech favorites as spintronics, high-temperature superconductors, ferroelectrics and ...
(Date:1/15/2014)... January 15, 2014 The Pittcon Organizing Committee ... Food Safety Tech , an e-Journal and producer of ... agreement for the second year for the co-location of Food ... The partnership provides that the registration fee to attend the ...
(Date:1/15/2014)... January 15, 2014 Look inside the ... items for the lab, from fluid handling to instruments ... to ship when you order. , Preferred Solutions ... , from the L/S® model for precise flow control ...
(Date:1/15/2014)... and SAN JOSE, California , January 15, ... developing antibody-drug conjugates for cancer, today announced the appointment of ... Dr Reynolds has over 20 years, development experience gained in ... Seattle Genetics. "I am delighted to welcome Tom ...
Breaking Biology Technology:A deeper look at interfaces 2Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3
... SAN FRANCISCO, July 20 Burrill & Company, a San ... Private Equity, Merchant Banking and Media, is pleased to announce that ... Director, for both Burrill & Company and Burrill Latin America. ... of Rio Bravo Venture Partners, an asset management firm created from ...
... BOZEN, Italy, July 20 Health ... with Charite-Universitatsmedizin,Berlin. Charite will install an i.v.STATION robot at ... The primary challenges in today,s ... time, waste, regulatory issues,lack of audit trails, motion injuries, ...
... , BASKING RIDGE, N.J., July ... the development of antithrombotic therapeutic aptamers with active control agents, ... Three new members (Dr. John Eikelboom of Canada, Dr. ... join the original members bringing the current size of the ...
Cached Biology Technology:Joao Paulo Baptista Joins Burrill & Company 2Health Robotics to Launch Germany's Installations of i.v.STATION(TM) at Charite-Universitatsmedizin Berlin 2Health Robotics to Launch Germany's Installations of i.v.STATION(TM) at Charite-Universitatsmedizin Berlin 3Regado Biosciences Expands Medical Advisory Board 2Regado Biosciences Expands Medical Advisory Board 3Regado Biosciences Expands Medical Advisory Board 4
(Date:4/24/2014)... 2014GEN Publishing recently introduced Clinical OMICs ... the application of OMICs technologies in clinical settings. ... beginning to transform medical care just as they ... decade-and-a-half. , "GEN,s editors and reporters have written ... transcriptomics, etc. etc. for years," said John Sterling, ...
(Date:4/24/2014)... invented a simple and cheap way of making a ... a high-resolution microscope. , Costing less than a cent, ... in developing countries and remote areas. , The lens ... The Australian National University (ANU) Research School of Engineering, ... Institute of Medical Research to find ways to transform ...
(Date:4/24/2014)... North Carolina State University and the University of North ... device that could help identify arterial plaque that is ... attack or stroke. , At issue is the plaque ... types of plaque are deemed "vulnerable," meaning that they ... and cause heart attack or stroke. , "Existing state-of-the-art ...
Breaking Biology News(10 mins):Droplet lens 2New ultrasound device may add in detecting risk for heart attack, stroke 2
... Assistant Professor, Department of Microbiology & Immunology, University of ... with one of two 2012 Merck Irving S. Sigal ... scientists to recognize and award excellence in basic research ... memory of Irving S. Sigal, an instrumental figure in ...
... Kaye Wachsmuth, Ph.D., International Public Health Consultant, DeLand, ... Public Health Award. This award, established in honor ... who has exhibited exemplary leadership and service in ... award "for almost forty years of implementing state-of-the-art ...
... Talk about throwing yourself into a relationship too soon. A ... gets a whiff of female sex attractant, he,s quicker to start ... prematurely when he,s still too cool for powerful flight. So his ... race. The study illustrates the tradeoff between being quick to ...
Cached Biology News:The American Society for Microbiology honors Susan Sharp 2The American Society for Microbiology honors I. Kaye Wachsmuth 2The American Society for Microbiology honors I. Kaye Wachsmuth 3Virgin male moths think they're hot when they're not 2Virgin male moths think they're hot when they're not 3Virgin male moths think they're hot when they're not 4Virgin male moths think they're hot when they're not 5
12 breakable polypropylene strips of 8 wells each held in a rigid frame. Ideal for antibody assays....
... in vitro diagnostic assays, all EIA/RIA plates ... uniform binding, high optical clarity and low ... part of the Certified Surface Chemistry Programme, ... within QA release specifications. Linkage: This CLS ...
... Stabilizer is an aqueous solution that contains ... stabilizing chemicals in a saline solution, pH ... of 0.02% methylisothiazolone and 0.02% bromonitrodioxane as ... a diluent and stabilizer for biologically active ...
AC input: 230 V...
Biology Products: